China’s Covid-19 vaccines reach final stage of WHO approval process

• Authorisation will pave the way for Sinopharm and Sinovac jabs to be included in the Covax Facility for equitable distribution
• Agency’s immunisation chief says formal review meetings have been scheduled, with the first one set for Monday